NexGelRx

NexGelRx is a healthcare-focused drug delivery company developing prescription transdermal and topical delivery solutions based on NEXGEL's proprietary electron beam-generated hydrogel technology. The business was originally created within NEXGEL and, as of December 2025, operates as a spun-off company focused specifically on Rx applications. Its platform is designed to enable ultra-gentle, high-water-content hydrogel patches and related delivery formats for pharmaceuticals, with potential use across pain, dermatology, hormone-related therapies, and other clinical areas. NexGelRx appears to be an early-stage platform company rather than a traditional single-asset therapeutic developer. NEXGEL remains its key strategic counterparty through an equity stake, a royalty arrangement, and exclusive hydrogel manufacturing supply.